The current head, John Crowley, a biotech executive and rare disease advocate, took over in March. GSK has spent slightly ...

Zantac was originated by GSK and launched by the company in the early 1980s, which sold it as a prescription and over-the-counter (OTC) product for indications like heartburn and acid indigestion ...

Zantac was originated by GSK and launched by the company in the early 1980s, which sold it as a prescription and over-the-counter (OTC) product for indications like heartburn and acid indigestion ...

Phenylephrine is widely used in a variety of over-the-counter flu and cold medicines, including popular products such as ...

British pharmaceutical company GSK on Wednesday said it swung into a net loss in the third quarter after settling lawsuits in the United States surrounding its Zantac heartburn drug.

GSK on Wednesday said its vaccine sales would fall this year, after a weaker-than-expected performance for its respiratory ...

Phenylephrine is widely used in a variety of over-the-counter flu and cold medicines, including popular products such as Benadryl ... the ingredient Companies such as Procter & Gamble and GSK were ...

An over-the-counter medication sold today as ... Tens of thousands of Zantac users have filed product liability lawsuits against GSK and other makers of versions of Zantac. This year, juries ...

GSK is on track to achieve its guidance for 2024, with its Q3 2024 and 9m 2024 results today. Explore more details here.

Corrects headline to say 'settlements' instead of 'settlement' British pharmaceutical company GSK said Wednesday ... ranitidine is carcinogenic. The over-the-counter treatment, known also by ...

To hear GSK CEO Emma Walmsley tell it, the third quarter presented “some challenges” for the drugmaker. | To hear GSK CEO ...

GSK's major growth drivers, Shingrix and Arexvy, along with recent legal progress, make its current undervaluation ...